BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22488604)

  • 1. Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing.
    Brausch JM; Connors KA; Brooks BW; Rand GM
    Rev Environ Contam Toxicol; 2012; 218():1-99. PubMed ID: 22488604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecotoxicology of human pharmaceuticals.
    Fent K; Weston AA; Caminada D
    Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of pharmaceuticals versus industrial chemicals acute aquatic toxicity classification according to the United Nations classification system for chemicals. Assessment of the (Q)SAR predictability of pharmaceuticals acute aquatic toxicity and their predominant acute toxic mode-of-action.
    Sanderson H; Thomsen M
    Toxicol Lett; 2009 Jun; 187(2):84-93. PubMed ID: 19429249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic aquatic environmental risks from exposure to human pharmaceuticals.
    Crane M; Watts C; Boucard T
    Sci Total Environ; 2006 Aug; 367(1):23-41. PubMed ID: 16762401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioconcentration, bioaccumulation, and metabolism of pesticides in aquatic organisms.
    Katagi T
    Rev Environ Contam Toxicol; 2010; 204():1-132. PubMed ID: 19957234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action.
    Christen V; Hickmann S; Rechenberg B; Fent K
    Aquat Toxicol; 2010 Feb; 96(3):167-81. PubMed ID: 20053463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for deriving pesticide aquatic life criteria.
    TenBrook PL; Tjeerdema RS; Hann P; Karkoski J
    Rev Environ Contam Toxicol; 2009; 199():19-109. PubMed ID: 19110939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata.
    Quinn B; Gagné F; Blaise C
    Sci Total Environ; 2008 Jan; 389(2-3):306-14. PubMed ID: 17931692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals in the environment: good practice in predicting acute ecotoxicological effects.
    Madden JC; Enoch SJ; Hewitt M; Cronin MT
    Toxicol Lett; 2009 Mar; 185(2):85-101. PubMed ID: 19118609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of personal care products in the aquatic environment: environmental concentrations and toxicity.
    Brausch JM; Rand GM
    Chemosphere; 2011 Mar; 82(11):1518-32. PubMed ID: 21185057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection.
    Roos V; Gunnarsson L; Fick J; Larsson DG; Rudén C
    Sci Total Environ; 2012 Apr; 421-422():102-10. PubMed ID: 22361586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment.
    Santos LH; Araújo AN; Fachini A; Pena A; Delerue-Matos C; Montenegro MC
    J Hazard Mater; 2010 Mar; 175(1-3):45-95. PubMed ID: 19954887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity tests aiming to protect Brazilian aquatic systems: current status and implications for management.
    Martins SE; Bianchini A
    J Environ Monit; 2011 Jul; 13(7):1866-75. PubMed ID: 21643562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of pharmaceuticals found in aquatic systems: comparison of PLHC-1 and RTG-2 fish cell lines.
    Caminada D; Escher C; Fent K
    Aquat Toxicol; 2006 Aug; 79(2):114-23. PubMed ID: 16828891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using data from drug discovery and development to aid the aquatic environmental risk assessment of human pharmaceuticals: concepts, considerations, and challenges.
    Winter MJ; Owen SF; Murray-Smith R; Panter GH; Hetheridge MJ; Kinter LB
    Integr Environ Assess Manag; 2010 Jan; 6(1):38-51. PubMed ID: 19558206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pharmaceuticals present in aquatic environment on Phase I metabolism in fish.
    Burkina V; Zlabek V; Zamaratskaia G
    Environ Toxicol Pharmacol; 2015 Sep; 40(2):430-44. PubMed ID: 26278678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment.
    Cooper ER; Siewicki TC; Phillips K
    Sci Total Environ; 2008 Jul; 398(1-3):26-33. PubMed ID: 18440598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating exposure into aquatic toxicological studies: an imperative.
    Wang WX
    Aquat Toxicol; 2011 Oct; 105(3-4 Suppl):9-15. PubMed ID: 22099340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxicity value extrapolation with fish and aquatic invertebrates.
    Buckler DR; Mayer FL; Ellersieck MR; Asfaw A
    Arch Environ Contam Toxicol; 2005 Nov; 49(4):546-58. PubMed ID: 16205993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.